UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$622M |
| 2 |
Mondelez International
MDLZ
|
+$579M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$418M |
| 4 |
Deutsche Bank
DB
|
+$340M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$333M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
NXP Semiconductors
NXPI
|
+$533M |
| 3 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$383M |
| 4 |
Hilton Worldwide
HLT
|
+$340M |
| 5 |
CERN
Cerner Corp
CERN
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.75% |
| 2 | Healthcare | 6.75% |
| 3 | Technology | 6.26% |
| 4 | Industrials | 5.06% |
| 5 | Consumer Discretionary | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6476
Champions Oncology
CSBR
$74.5M
| $14K | ﹤0.01% |
5,490
+1,223
| +29% | +$3.19K |
|
6477
Citi Trends
CTRN
$555M
| $14K | ﹤0.01% |
655
+231
| +54% | +$4.36K |
|
6478
Dare Bioscience
DARE
$18.3M
| $14K | ﹤0.01% |
260
+83
| +47% | +$4.82K |
|
|
DRRX
6479
DELISTED
DURECT Corp
DRRX
| $14K | ﹤0.01% |
859
-111
| -11% | -$1.26K |
|
6480
ProShares Trust UltraShort MSCI Emerging Markets
EEV
$2.42M
| $14K | ﹤0.01% |
+126
| New | +$15K |
|
6481
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.31M
| $14K | ﹤0.01% |
273
-2,476
| -90% | -$128K |
|
6482
Franklin Covey
FC
$242M
| $14K | ﹤0.01% |
706
+413
| +141% | +$8.52K |
|
6483
Goldgroup Mining Inc.
GORO
$157M
| $14K | ﹤0.01% |
3,500
+1,000
| +40% | +$3.8K |
|
6484
FerroAtlántica
GSM
$594M
| $14K | ﹤0.01% |
1,194
+137
| +13% | +$1.39K |
|
6485
Hallador Energy
HNRG
$670M
| $14K | ﹤0.01% |
1,764
-683
| -28% | -$5.12K |
|
6486
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$75.9M
| $14K | ﹤0.01% |
661
-1,613
| -71% | -$34.9K |
|
6487
Intellicheck
IDN
$73.1M
| $14K | ﹤0.01% |
3,634
+3,334
| +1,111% | +$11.8K |
|
6488
SemiLEDS
LEDS
$17.6M
| $14K | ﹤0.01% |
5,431
+4,394
| +424% | +$13.1K |
|
6489
Myomo
MYO
$39M
| $14K | ﹤0.01% |
+43
| New | +$15.8K |
|
|
NNDM
6490
Nano Dimension
NNDM
$324M
| $14K | ﹤0.01% |
225
+182
| +423% | +$11.6K |
|
6491
Ocugen
OCGN
$416M
| $14K | ﹤0.01% |
132
-48
| -27% | -$4.92K |
|
|
QNRX
6492
Quoin Pharmaceuticals
QNRX
$8.94M
| – | – |
0
| – | – |
|
6493
CALL
Sabesp
SBS
$19.1B
| $14K | ﹤0.01% |
+7,735
| New | +$14.3K |
|
6494
Silicom
SILC
$229M
| $14K | ﹤0.01% |
322
+149
| +86% | +$7.34K |
|
|
SOL
6495
DELISTED
Emeren Group
SOL
| $14K | ﹤0.01% |
5,822
+4,255
| +272% | +$10.8K |
|
6496
United Bancorp
UBCP
$90.7M
| $14K | ﹤0.01% |
1,147
-264
| -19% | -$3.13K |
|
|
GVP
6497
DELISTED
GSE Systems, Inc.
GVP
| $14K | ﹤0.01% |
474
+149
| +46% | +$4.91K |
|
|
ALPN
6498
DELISTED
Alpine Immune Sciences Inc
ALPN
| $14K | ﹤0.01% |
+1,445
| New | +$13.8K |
|
|
AFTY
6499
DELISTED
Pacer CSOP FTSE China A50 ETF
AFTY
| $14K | ﹤0.01% |
881
+879
| +43,950% | +$12.5K |
|
|
FRGI
6500
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $14K | ﹤0.01% |
698
-63,344
| -99% | -$1.44M |
|
Similar funds
UBS Group's Q2 2017 Portfolio in Review
As of Q2 2017, UBS Group held 8,497 positions worth $193B, up 5.4% from $183B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2017 filing shows 756 new, 3,610 increased, 2,944 reduced and 742 closed positions. Its largest new stake was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Financials at 7.7% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Technology.
- UBS Group's largest Q2 2017 buy was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M.
- UBS Group added most to Monsanto Co in Q2 2017, an estimated $622M increase.
- UBS Group's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- UBS Group fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $383M.
- UBS Group's ten largest holdings make up 13% of its $193B portfolio in Q2 2017.
- UBS Group opened 756 new positions and closed 742 in Q2 2017.
- UBS Group's portfolio value rose 5.4% quarter-over-quarter to $193B.
Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.